We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FWDI:NASDAQForward Industries, Inc. Analysis

Data as of 2026-08-26 - not real-time

$6.05

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Forward Industries, Inc. trades at $6.05, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 33.3%. With RSI at 77.9 the momentum picture is overbought, alongside a bullish MACD signal. The recent range runs from support at $3.77 up to resistance at $6.30.
The shares look undervalued at 31.0 times earnings, though no sector average was available for comparison. Consensus targets land 29.5% above where the shares trade now. Revenue is growing at 332.1%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 73.7%, a beta of 3.73 and a maximum drawdown of 90.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.

Top Market Events

Forward Industries FWDI is scheduled to announce Q3 earnings results on Wednesday, August 12th, after market close.Forward Industries Inc FWDI reports a net loss driven by digital asset volatility, but highlights strong SOL growth,...Investornewsbreaks Forward Industries Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • RSI at 77.9 signals overbought conditions
  • Trading above the 200-day average of 5.52
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • RSI at 77.9 signals overbought conditions
  • Trading above the 200-day average of 5.52
  • Analyst targets imply +29.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +29.5% versus the current price
  • Negative return on equity of -461.4%
  • Revenue growth of +332.1%

Key Metrics & Analysis

Financial Health

Revenue Growth332.10%
P/E Ratio31.0
ROE-461.37%
ROA2.05%
Debt/Equity24.99
P/B Ratio0.9
Op. Cash Flow$-18381304
Free Cash Flow$14.8M

Technical Analysis

TrendNeutral
RSI77.9
Support$3.77
Resistance$6.30
MA 20$4.50
MA 50$4.36
MA 200$5.52
MACDBullish
VolumeIncreasing
Fear & Greed Index93.38

Valuation

Fair Value$5.55
Target Price$7.83
Upside/Downside29.48%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta3.73
Volatility73.72%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.